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INTRODUCTION AND OBJECTIVES:  
Neonatal care advancements have increased 
the survival of premature babies, who often 
have morbidities requiring feedings via 
nasogastric (NG) or G tube (Figure 1). The 
reason for feeding problems may be 
multifactorial, leading to different outcomes 
for NG and G tube use. An NG tube is 
preferred for short-term use to prevent 
complications from GT placement. For long-
term assistance, GT is recommended for its 
stability, lower potential for respiratory 
complications, and superior anthropometric 
outcomes. However, in many cases it is not 
possible to anticipate how long a feeding tube 
may be needed. We reviewed charts of NICU 
patients with GT placement regarding length 
of time of GT use to identify patients who 
could have been discharged with NG tube 
and avoided surgery. 
The aim of this pilot study of NICU babies 
was to predict the need for tube feedings of a 
duration >2 months so that patients with a 
requirement of <2 months can be discharged 
with an NG tube, thereby decreasing the risks 
of GT placement and decreasing the cost of 
health care. A larger study can identify 
clinical characteristics that may help 
determine the duration of feeding assistance 
needed in NICU babies. 
 
 
Figure 1. Nasogastric (NG) tube feeding 
(left) and gastrostomy tube (GT) feeding in 
an infant 
 
METHODS: A retrospective chart review 
was done for patients (n=156) with GT in 
NICU from January 2011 to May 2015. 
Patients were followed up regarding GT use 
until GT removal or for >1 year. Clinical 
parameters were compared between patients 
requiring GT for <2 months (n=29) vs. >2 
months (n=124). Logistic regression 
statistical analysis was used to identify 
parameters that can predict short-term GT 
need. 
 
RESULTS: Of 156 patients, 3 were excluded 
(lost to follow up). There were 29 patients 
who used the GT for <2 months and 124 
patients who used the GT for >2 months. 
Model 1 factored in the effects of birth 
weight, percent PO intake at time of GT 
placement, presence of chromosomal 
abnormality, and presence of CNS disease 
(Figure 2). There was an interaction between 
birth weight and presence of chromosomal 
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abnormality. A 1-unit increase in percent PO 
intake at time of GT placement had a 3% 
significant decrease in odds of having the GT 
for >2 months (P=0.005). Among babies with 
a chromosome abnormality, there was a 0.2%  
Figure 2. As birth weight increases, the 
probability of GT use for >2 months 
increases in the presence of a chromosome 
abnormality and stays the same in the 
absence of a chromosome abnormality. 
 
significant increase in odds of having the GT 
for >2 months for every 1-gram increase in 
weight compared to babies that do not have a 
chromosome abnormality (P=0.049). 
Model 2 factored in the effects of gender, 
gestational age, delivery method, presence of 
CNS disease, presence of GI disease, 
presence of lung disease, and presence of 
other disease (Figure 3). There was an 
interaction between the presence of CNS 
disease and gestational age. Among babies 
with a CNS disease, there was an 18% 
significant increase in odds of having the GT 
for >2 months for every 1-unit increase in 
gestational age compared to babies that do 
not have a CNS disease (P=0.048). 
The following parameters were not 
significantly different between the two 
groups of patients: cardiovascular disease, 
cleft palate, renal disease, infant of diabetic 
mother, intrauterine growth restriction, other 
disease, GI consult obtained before 
procedure, postoperative complications, and 
GT removal (data not shown). 
Figure 3. As gestational age increases, the 
probability of GT use for >2 months 
increases in the presence of CNS disease and 
decreases in the absence of CNS disease. 
 
CONCLUSIONS:  
1. Higher percentage PO intake at time of 
GT placement was associated with short-
term GT use. 
2. Longer-term GT need may be predicted 
by presence of chromosome abnormality 
for babies with higher birth weights. 
3. Longer-term GT need may be predicted 
by presence of CNS disease for higher 
gestational age babies. 
4. Statistical analysis was limited by the 
number of patients. Future research 
including a larger number of patients who 
used a GT for <2 months can yield more 
insight into clinical parameters that may 
be used to determine the need for NG vs. 
G tube in NICU babies to minimize risks 
and optimize outcomes. 
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